Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GSK1349572 Repeat Dose Escalation Study

NCT00631592 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT00631592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00631592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GSK1349572 Repeat Dose Escalation Study
Lead sponsor
ViiV Healthcare
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2008
Completion date
June 30, 2008
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects